Overview
Glytec is the market leader in diabetes management and insulin dosing. Founded in 2006 as the first FDA-cleared software for insulin management, we currently serve over 400 hospitals nationwide.
Insulin management issues are one of the top three adverse events in the United States. Each year, approximately two million of these events take place, costing Medicare about $8 billion. Most of these issues are due to hospitals using paper systems rather than online solutions, which integrate directly into electronic medical records (EMRs).
Glytec’s industry-leading SaaS platform for diabetes and insulin management impacts over 40% of your patients and advances your metrics for the new mandatory CMS quality measures for glycemic control.
Our value proposition: Annual cost savings of $4.5 million for a 1,000-bed hospital and proven 6-8x return on investment.
Glytec’s Diabetes and Insulin Management Platform
Point-of-care Insulin Dosing
- FDA-cleared
- Cloud-based
- Easy integration
- Simple clinician workflows
Executive Diabetes Control Center
- Holistic view across system, hospitals and units
- Real-time insights and alerts
- Risk-based workflows and prioritization
- Executive-level personas
Professional Services
Expert Transformation Support
- Certified experts in glycemic management
- Tailored clinical strategies
- Comprehensive support
- Proven results
Benefits
- Improve patient outcomes with excellence in glycemic management
- Achieve cost savings via improved outcomes
- Increase revenue by improving throughput and ICU availability
- Reduce liability using an FDA-cleared HITRUST solution
- Navigate CMS mandate through addressing new eCQM reporting requirements
- Seamlessly integrates with your existing EHR and workflows, offering best-in-class cloud and security infrastructure
Resources / Links
Website:
https://glytec.com
One-pager:
Driving Outcomes, Revenue, and Cost Savings
Case Study:
Hospital Moves to Basal-Bolus Insulin, Saves $9.7 Million
Executive Brief:
Insulin Management, Optimized
HRSA Request:
Supporting Rural Hospitals’ Glycemic Management Standards
More Resources:
Information Hub
CMS Reporting Requirements:
On Aug. 1, 2024, CMS released its fiscal year (FY) 2025 Inpatient Prospective Payment System (IPPS)/Long-Term Care Hospital Prospective Payment System (LTCH PPS) final rule. Hospitals will be required to report on both the Severe Hyperglycemia and Severe Hypoglycemia electronic clinical quality measures (eCQMs) beginning with the CY 2026 Reporting Period/FY 2028 Payment Determination.
